Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
Forward 50 2014

Alan Blassberg

Alan Blassberg can’t enter a Cheesecake Factory restaurant without thinking about breast cancer.

That’s where he was lunching when he got the call that his sister Sammy Blassberg had been diagnosed. The call would turn Blassberg from documentary filmmaker to activist.

Sammy Blassberg died in 2010, at age 47. That same year, Blassberg’s other sister Lisa Brandes was tested for the BRCA mutation, carried by one in 40 Ashkenazi Jews, which significantly increases one’s risk for cancer. After “much Jewish guilt,” she finally convinced Blassberg to do the same.

Both were positive. Lisa chose to undergo a prophylactic double mastectomy. Blassberg chose to make a movie.

Men with a BRCA mutation face a 5% to 10% lifetime risk of breast cancer, in contrast to a 0.1% lifetime risk for men in the general population. For women, those risks run closer to 80%, perhaps partially explaining why men get lost in the shuffle.

Seeking to address the lack of awareness and stigma surrounding male breast cancer, Blassberg started a Kickstarter campaign. “Pink & Blue,” a documentary that follows both men and women dealing with a breast cancer diagnosis, raised $75,500 in just 34 days. Since December 2013, Blassberg, 44, has filmed in 10 cities across America and interviewed more than 50 people.

“At the end of the day, if I can save one family from having to hear a relative moan in pain… that’s all I could ask for,” he told the Forward.

“There’s such social stigma about the word ‘breast.’ It doesn’t matter. Save your lives.”

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.